DAVID BECK: Open Payments
NPI 1679646350 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 28 payments from 11 companies in 2025. Trend: 2023 $1,042 · 2024 $1,086 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $201 |
| GENZYME CORPORATION | 1 | $122 |
| ABBVIE INC. | 4 | $90 |
| Novo Nordisk Inc | 4 | $83 |
| Lilly USA, LLC | 3 | $59 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| Exact Sciences Corporation | 2 | $34 |
| Abbott Laboratories | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
Products named: DUPIXENT, REPATHA, OTEZLA, MOUNJARO, INSPIRE, Rybelsus, UBRELVY, FREESTYLE LIBRE 3.
Industry payments across AZ — which companies pay providers there.
